Briacell Therap (BCTX) Short Interest Ratio & Short Volume $0.71 +0.03 (+4.58%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$0.72 +0.00 (+0.03%) As of 08/8/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Briacell Therap Short Interest DataBriacell Therap (BCTX) has a short interest of 1.79 million shares, representing 10.57% of the float (the number of shares available for trading by the public). This marks a 442.59% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.0, indicating that it would take 1.0 days of the average trading volume of 2.17 million shares to cover all short positions.Current Short Interest1,790,000 sharesPrevious Short Interest329,900 sharesChange Vs. Previous Month+442.59%Dollar Volume Sold Short$1.38 millionShort Interest Ratio1.0 Days to CoverLast Record DateJuly 15, 2025Outstanding Shares6,780,000 sharesFloat Size16,930,000 sharesShort Percent of Float10.57%Today's Trading Volume571,180 sharesAverage Trading Volume2,170,262 sharesToday's Volume Vs. Average26% Short Selling Briacell Therap? Sign up to receive the latest short interest report for Briacell Therap and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBCTX Short Interest Over TimeBCTX Days to Cover Over TimeBCTX Percentage of Float Shorted Over Time Briacell Therap Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/20251,790,000 shares $1.38 million +442.6%10.6%1 $0.77 6/30/2025329,900 shares $969.91 thousand +56.9%5.2%0.2 $2.94 6/15/2025210,300 shares $656.14 thousand -59.4%3.3%0.1 $3.12 5/31/2025517,500 shares $1.77 million +205.0%9.7%0.4 $3.42 5/15/2025169,700 shares $495.52 thousand -39.3%3.2%0.1 $2.92 4/30/2025279,400 shares $1.25 million +35.0%5.2%0.2 $4.46 4/15/2025206,900 shares $775.88 thousand +7.8%6.0%0.1 $3.75 3/31/2025191,900 shares $700.44 thousand +2.0%5.5%0.6 $3.65 3/15/2025188,100 shares $722.30 thousand +2.2%5.4%0.6 $3.84 2/28/2025184,100 shares $675.65 thousand -9.0%5.4%0.5 $3.67 Get the Latest News and Ratings for BCTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Briacell Therap and its competitors with MarketBeat's FREE daily newsletter. 2/15/2025202,300 shares $880.01 thousand +113.4%5.9%0.5 $4.35 1/31/202594,800 shares $475.90 thousand -94.2%2.8%0.3 $5.02 1/15/20251,620,000 shares $9.72 million -1.8%4.0%1.2 $6.00 12/31/20241,650,000 shares $932.25 thousand -30.7%4.2%1.1 $0.57 12/15/20242,380,000 shares $1.57 million +245.7%6.0%1 $0.66 11/30/2024688,400 shares $676.28 thousand +28.7%2.1%0.1 $0.98 11/15/2024534,800 shares $318.21 thousand -28.2%1.7%0.1 $0.60 10/31/2024745,100 shares $605.92 thousand +2.4%2.3%0.2 $0.81 10/15/2024727,600 shares $654.62 thousand +62.0%2.3%0.2 $0.90 9/30/2024449,200 shares $557.01 thousand -72.8%1.6%0.1 $1.24 9/15/20241,650,000 shares $924.83 thousand +549.1%6.7%0.5 $0.56 8/31/2024254,200 shares $200.21 thousand -39.1%1.7%0.1 $0.79 8/15/2024417,200 shares $236.97 thousand -10.2%2.7%1.1 $0.57 7/31/2024464,400 shares $349.46 thousand -18.4%3.0%1.2 $0.75 7/15/2024569,400 shares $529.54 thousand +1.1%3.7%1.6 $0.93 6/30/2024563,300 shares $642.16 thousand -10.4%3.6%4.7 $1.14 6/15/2024628,300 shares $892.19 thousand -12.6%4.1%5.2 $1.42 5/31/2024718,900 shares $1.21 million +11.3%4.8%5.9 $1.69 5/15/2024645,700 shares $1.08 million -3.3%4.3%5.6 $1.68 4/30/2024667,700 shares $1.45 million -2.5%4.8%8.9 $2.17 4/15/2024685,000 shares $1.59 million +1.1%4.9%8.1 $2.32 3/31/2024677,900 shares $1.94 million -7.6%4.8%7.2 $2.86 3/15/2024733,300 shares $2.16 million -7.9%5.2%6.8 $2.95 2/29/2024795,900 shares $2.75 million -2.8%5.7%7.7 $3.46 2/15/2024818,800 shares $2.64 million -6.1%5.8%8.3 $3.23 1/31/2024871,900 shares $3.59 million +1.0%6.2%9.2 $4.12 1/15/2024863,700 shares $3.79 million +0.6%6.2%7.6 $4.39 12/31/2023858,500 shares $5.02 million +1.6%6.1%8 $5.85 12/15/2023845,200 shares $3.49 million -11.2%6.0%8.8 $4.13 11/30/2023951,900 shares $5.04 million -2.8%6.8%10.5 $5.29He Called Nvidia at $1.10. Now, He Says THIS Stock Will… (Ad)The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvidia at $1.10 reveals AI’s Next Magnificent Seven… including one stock he says could become America’s next trillion-dollar giant.See his full breakdown of the seven stocks to own now 11/15/2023979,100 shares $4.31 million +3.8%7.0%10 $4.40 10/31/2023943,400 shares $4.01 million -7.5%7.1%9.2 $4.25 10/15/20231,020,000 shares $5.00 million -2.9%7.7%12 $4.90 9/30/20231,050,000 shares $6.56 million -3.7%8.0%12.5 $6.25 9/15/20231,090,000 shares $6.63 million -3.5%8.3%11.8 $6.08 8/31/20231,130,000 shares $8.12 million +3.7%8.6%11.9 $7.19 8/15/20231,090,000 shares $7.54 million +3.8%8.3%11.8 $6.92 7/31/20231,050,000 shares $7.02 million +1.0%8.0%10 $6.69 7/15/20231,040,000 shares $6.71 million -1.0%9.1%9.4 $6.45 6/30/20231,050,000 shares $6.74 million -4.6%9.2%8.4 $6.42 6/15/20231,100,000 shares $6.67 million -12.7%9.7%8.8 $6.06 5/31/20231,260,000 shares $7.47 million -6.0%11.4%9.9 $5.93 5/15/20231,340,000 shares $8.80 million -3.6%12.2%9.6 $6.57 4/30/20231,390,000 shares $10.34 million -4.1%12.6%9.1 $7.44 4/15/20231,450,000 shares $10.44 million +1.4%13.2%8.6 $7.20 3/31/20231,430,000 shares $10.65 million -4.7%13.9%7.6 $7.45 3/15/20231,500,000 shares $10.50 million -6.3%14.6%7.1 $7.00 2/28/20231,600,000 shares $11.33 million +4.6%15.5%7.2 $7.08 2/15/20231,530,000 shares $12.22 million +1.3%14.9%6.7 $7.99 1/31/20231,510,000 shares $11.29 million +15.3%14.7%6.7 $7.48 1/15/20231,310,000 shares $8.71 million -0.8%12.6%5.1 $6.65 12/30/20221,320,000 shares $5.77 million -5.7%12.7%5.6 $4.37 12/15/20221,400,000 shares $7.87 million No Change13.5%5.6 $5.62 11/30/20221,400,000 shares $7.52 million No Change13.5%4.1 $5.37 11/15/20221,400,000 shares $7.69 million +12.9%13.5%3.8 $5.49 10/31/20221,240,000 shares $6.82 million -10.1%11.9%3.2 $5.50 10/15/20221,380,000 shares $9.12 million +3.8%13.3%3.4 $6.61 9/30/20221,330,000 shares $7.47 million -16.9%12.8%3.4 $5.62 9/15/20221,600,000 shares $12.91 million +2.6%15.4%3.9 $8.07 8/31/20221,560,000 shares $12.12 million +4.0%15.0%4.2 $7.77 8/15/20221,500,000 shares $10.34 million -4.5%14.4%4.3 $6.89 7/31/20221,570,000 shares $10.21 million -10.8%15.7%4.2 $6.50 7/15/20221,760,000 shares $10.70 million +8.0%15.1%4.6 $6.08 6/30/20221,630,000 shares $9.41 million -0.6%14.0%2 $5.77 6/15/20221,640,000 shares $10.61 million -3.0%14.1%1.9 $6.47 5/31/20221,690,000 shares $8.47 million -0.6%14.8%2.1 $5.01 5/15/20221,700,000 shares $8.40 million -9.1%14.9%2 $4.94 4/30/20221,870,000 shares $13.02 million -24.3%15.7%2.2 $6.96 4/15/20222,470,000 shares $21.27 million +27.3%19.4%2.6 $8.61 3/31/20221,940,000 shares $19.67 million No Change15.1%3.2 $10.14 3/15/20221,940,000 shares $15.62 million +6.0%15.1%3.3 $8.05 2/28/20221,830,000 shares $13.96 million No Change13.7%2.1 $7.63 2/15/20221,830,000 shares $14.02 million +10.2%13.7%1.5 $7.66 1/31/20221,660,000 shares $10.49 million -5.7%13.2%1.2 $6.32 1/15/20221,760,000 shares $14.87 million +17.3%14.0%1.2 $8.45 12/31/20211,500,000 shares $12.42 million -13.3%12.0%1 $8.28 12/15/20211,730,000 shares $13.82 million -8.0%13.9%0.9 $7.99 11/30/20211,880,000 shares $18.50 million +8.1%15.8%0.9 $9.84 11/15/20211,740,000 shares $16.58 million +5.5%14.4%0.9 $9.53 10/29/20211,650,000 shares $13.12 million -15.0%13.7%0.8 $7.95He Called Nvidia at $1.10. Now, He Says THIS Stock Will… (Ad)The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvidia at $1.10 reveals AI’s Next Magnificent Seven… including one stock he says could become America’s next trillion-dollar giant.See his full breakdown of the seven stocks to own now 10/15/20211,940,000 shares $15.89 million -16.7%16.2%0.9 $8.19 9/30/20212,330,000 shares $18.87 million +22.6%19.5%1 $8.10 9/15/20211,900,000 shares $13.62 million +10.5%15.9%0.9 $7.17 8/31/20211,720,000 shares $11.68 million +4.9%14.6%0.7 $6.79 8/13/20211,640,000 shares $9.84 million No Change14.0%0.4 $6.00 BCTX Short Interest - Frequently Asked Questions What is Briacell Therap's current short interest? Short interest is the volume of Briacell Therap shares that have been sold short but have not yet been closed out or covered. As of July 15th, traders have sold 1,790,000 shares of BCTX short. 10.57% of Briacell Therap's shares are currently sold short. Learn More on Briacell Therap's current short interest. What is a good short interest ratio for Briacell Therap? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BCTX shares currently have a short interest ratio of 1.0. Learn More on Briacell Therap's short interest ratio. What is a good short interest percentage for Briacell Therap? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 10.57% of Briacell Therap's floating shares are currently sold short. Is Briacell Therap's short interest increasing or decreasing? Briacell Therap saw a increase in short interest in the month of July. As of July 15th, there was short interest totaling 1,790,000 shares, an increase of 442.6% from the previous total of 329,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Briacell Therap's float size? Briacell Therap currently has issued a total of 6,780,000 shares. Some of Briacell Therap's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Briacell Therap currently has a public float of 16,930,000 shares. How does Briacell Therap's short interest compare to its competitors? 10.57% of Briacell Therap's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Briacell Therap: Relmada Therapeutics, Inc. (1.28%), Equillium, Inc. (5.19%), Finch Therapeutics Group, Inc. (0.01%), Imunon, Inc. (0.07%), BioAtla, Inc. (7.27%), 180 Life Sciences Corp. (1.89%), Chemomab Therapeutics Ltd. Sponsored ADR (1.03%), Hoth Therapeutics, Inc. (3.05%), Cadrenal Therapeutics, Inc. (1.53%), Passage Bio, Inc. (4.04%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks. What does it mean to sell short Briacell Therap stock? Short selling BCTX is an investing strategy that aims to generate trading profit from Briacell Therap as its price is falling. BCTX shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Briacell Therap? A short squeeze for Briacell Therap occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BCTX, which in turn drives the price of the stock up even further. How often is Briacell Therap's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BCTX, twice per month. The most recent reporting period available is July, 15 2025. More Short Interest Resources from MarketBeat Related Companies Relmada Therapeutics Short Interest Equillium Short Interest Finch Therapeutics Group Short Interest Imunon Short Interest BioAtla Short Interest 180 Life Sciences Short Interest Chemomab Therapeutics Short Interest Hoth Therapeutics Short Interest Cadrenal Therapeutics Short Interest Passage Bio Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BCTX) was last updated on 8/9/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Briacell Therap Please log in to your account or sign up in order to add this asset to your watchlist. Share Briacell Therap With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BCTX Stock Alerts